Benitec Biopharma Inc

General ticker "BNTC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $122.1M

Benitec Biopharma Inc follows the US Stock Market performance with the rate: 48.1%.

Estimated limits based on current volatility of 4.7%: low 10.92$, high 11.89$

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-06-30 to 2026-06-30

  • 2024-06-30 to 2025-06-30 estimated range: [4.20$, 11.75$]
  • 2025-06-30 to 2026-06-30 estimated range: [2.02$, 6.39$]

Financial Metrics affecting the BNTC estimates:

  • Negative: Non-GAAP EPS, $ of -8.36 <= 0.10
  • Negative: Operating profit margin, % of -99.05 <= 1.03
  • Negative: Operating cash flow per share per price, % of -39.31 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Industry operating profit margin (median), % of -100 <= 2.14

Similar symbols

Short-term BNTC quotes

Long-term BNTC plot with estimates

Financial data

YTD 2022-06-30 2023-06-30 2024-06-30
Operating Revenue $0.07MM $0.07MM $0.22MM
Operating Expenses $17.93MM $19.16MM $22.71MM
Operating Income $-17.85MM $-19.08MM $-22.49MM
Non-Operating Income $-0.35MM $-0.48MM $0.12MM
Interest Expense $0.03MM $0.03MM $0.90MM
R&D Expense $11.27MM $12.77MM $15.61MM
Income(Loss) $-18.21MM $-19.56MM $-22.37MM
Taxes $0.00MM $0.00MM $-0.62MM
Profit(Loss) $-18.21MM $-19.56MM $-21.75MM
Stockholders Equity $2.88MM $0.20MM $47.25MM
Inventory $0.00MM $0.01MM $0.00MM
Assets $5.97MM $4.46MM $52.21MM
Operating Cash Flow $-15.90MM $-18.01MM $-19.40MM
Capital expenditure $0.01MM $0.00MM $0.18MM
Investing Cash Flow $-0.01MM $-0.00MM $-0.18MM
Financing Cash Flow $0.20MM $16.43MM $68.03MM
Earnings Per Share* $-38.62 $-14.12 $-5.36

* EPS are Split Adjusted, recent splits may be reflected with a delay.